Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
出版年份 2018 全文链接
标题
Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 5, Pages 1524
出版商
MDPI AG
发表日期
2018-05-21
DOI
10.3390/ijms19051524
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of Wnt Co-Receptor LRP6 in Triple Negative Breast Cancer Cell Migration and Invasion
- (2017) Jinlu Ma et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma
- (2016) K. Satoh et al. CLINICAL CANCER RESEARCH
- Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family
- (2016) Mohammed A. Suliman et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer
- (2016) Rebecca C. Arend et al. Oncotarget
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- Niclosamide Analogs for Treatment of Ovarian Cancer
- (2015) Christen L. Walters Haygood et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition
- (2015) Chengfei Liu et al. PROSTATE
- A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells
- (2015) B Chu et al. Cell Death & Disease
- Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
- (2015) Sylvie Maubant et al. PLoS One
- Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype
- (2015) Gyu-Beom Jang et al. Scientific Reports
- Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
- (2014) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- Selective ALDH3A1 Inhibition by Benzimidazole Analogues Increase Mafosfamide Sensitivity in Cancer Cells
- (2014) Bibek Parajuli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of Niclosamide on Basal-like Breast Cancers
- (2014) A. I. Londono-Joshi et al. MOLECULAR CANCER THERAPEUTICS
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
- (2014) Tinghong Ye et al. PLoS One
- Wnt signaling in triple negative breast cancer is associated with metastasis
- (2013) Nandini Dey et al. BMC CANCER
- Therapeutic targets in triple negative breast cancer
- (2013) Sandra A O'Toole et al. JOURNAL OF CLINICAL PATHOLOGY
- Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells
- (2013) Birdal Bilir et al. Journal of Translational Medicine
- Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer
- (2013) S. Yin et al. MOLECULAR CANCER THERAPEUTICS
- Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer
- (2013) S. You et al. MOLECULAR CANCER THERAPEUTICS
- Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
- (2013) Yu-Chi Wang et al. PLoS One
- Paracrine Wnt signaling both promotes and inhibits human breast tumor growth
- (2013) J. L. Green et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling
- (2012) Bruno D. Fonseca et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 6-Nitrobenzimidazole derivatives: Potential phosphodiesterase inhibitors: Synthesis and structure–activity relationship
- (2011) K.M. Khan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
- (2011) T. Osada et al. CANCER RESEARCH
- Niclosamide: An Established Antihelminthic Drug as a Potential Therapy Against S100A4-Mediated Metastatic Colon Tumors
- (2011) D. M. Helfman JNCI-Journal of the National Cancer Institute
- Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
- (2011) U. Sack et al. JNCI-Journal of the National Cancer Institute
- FZD7 has a critical role in cell proliferation in triple negative breast cancer
- (2011) L Yang et al. ONCOGENE
- Molecular Stratification of Triple-Negative Breast Cancers
- (2011) C. M. Perou ONCOLOGIST
- Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
- (2011) Wenyan Lu et al. PLoS One
- Antitumorigenic potential of STAT3 alternative splicing modulation
- (2011) F. Zammarchi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
- (2011) Desheng Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production
- (2011) F L Khanim et al. Blood Cancer Journal
- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
- (2010) Andrey I. Khramtsov et al. AMERICAN JOURNAL OF PATHOLOGY
- Cytoplasmic Localization of -Catenin is a Marker of Poor Outcome in Breast Cancer Patients
- (2010) E. Lopez-Knowles et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
- (2010) Felipe C Geyer et al. MODERN PATHOLOGY
- LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
- (2010) C.-C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
- (2010) Xiaomei Ren et al. ACS Medicinal Chemistry Letters
- The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
- (2009) Minyong Chen et al. BIOCHEMISTRY
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
- (2009) Bryan T. MacDonald et al. DEVELOPMENTAL CELL
- The autonomous notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells
- (2009) An-Ming Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Synthesis and Evaluation of a New Generation of Orally Efficacious Benzimidazole-Based Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors as Anticancer Agents
- (2009) Yunsong Tong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer
- (2009) Baozhi Chen et al. Nature Chemical Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started